Radiopharm Theranostics Ltd (RADX) Debt Ratio (2024 - 2026)

Radiopharm Theranostics (RADX) has reported Debt Ratio for 3 consecutive years, with 0.43 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Debt Ratio rose 15.48% year-over-year to 0.43 in Q2 2026; TTM through Jun 2026 was 0.43, a 15.48% increase from a year earlier, with the FY2026 full-year figure at 0.43, up 15.48% from the prior year.
• Debt Ratio was 0.43 for Q2 2026 at Radiopharm Theranostics, up from 0.37 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.46 in Q2 2024 and troughed at 0.32 in Q4 2024.
• A 3-year average of 0.4 and a median of 0.4 in 2025 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio decreased 20.01% in 2025 and advanced 15.48% in 2026, its largest moves.
• Over 3 years, Debt Ratio stood at 0.32 in 2024, then advanced by 16.14% to 0.37 in 2025, then advanced by 15.48% to 0.43 in 2026.
• The last three Debt Ratio figures came in at 0.43 (Q2 2026), 0.37 (Q2 2025), and 0.32 (Q4 2024), per Business Quant data.